CTP - Solution

100 mM Sodium salt solution

Cytidine 5'-triphosphate, Sodium salt

Catálogo Nº Apresentação Preço (R$) Comprar / Observação
NU-1011 1 ml (100 mM) Sob demanda Adicionar ao Carrinho
Structural formula of CTP - Solution (100 mM Sodium salt solution, Cytidine 5'-triphosphate, Sodium salt)
Structural formula of CTP - Solution

For general laboratory use.

Envio: shipped on gel packs

Condições de armazenamento: store at -20 °C
Short term exposure (up to 1 week cumulative) to ambient temperature possible. If stored as recommended, Jena Bioscience guarantees optimal performance of this product for 12 months after date of delivery.

Validade: 12 months

Fórmula molecular: C9H16N3O14P3 (free acid)

Peso molecular: 483.16 g/mol (free acid)

CAS#: 36051-68-0

Número CE: 252-849-3

Pureza: ≥ 99 % (HPLC)

Forma: clear aqueous solution

Concentração: 100 mM ±2 %

pH: 8.0 ±0.2 (22 °C)

Propriedades espectroscópicas: λmax 271 nm, ε 8.9 L mmol-1 cm-1 (Tris-HCl pH 7.0)

Formulários:
Physiological role in coronary artery disease[1]
Physiolocal role in lipid metabolism[2]
Physiological role in farnesol induced apoptosis[3]

Descrição:
Ultrapure CTP supplied as clear aqueous solution.

Specific Ligands: CTP synthase[4] Phosphocholine cytidyltransferase alpha[2] Ligand for purinergic receptors: P2Y6[5] P2X3[6]

Referências selecionadas:
[1] Lui et al. (2010) Evaluation of CT perfusion in setting of cerebral ischemia:patterns and pitfalls. American Journal of Neuroradiology 31:1552.

[2] Luoma (2010) Gene activation regresses artheriosclerosis, promotes health, and enhances longevity. Lipids in health and disease 9:67.

[3] Joo et al. (2010) Molecular mechanisms involved in farnesol-induced apotosis. Cancer letters 287:123.

[4] Cabeen et al. (2010) A metabolic assembly line in bacteria. Nature Cell Biology 12:731.

[5]Jayasekara et al. (2013) 4-Alkoxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y6 receptor. MedChemComm. 4 (8):1156.

[6]Garzia-Guzman et al. (1997) Molecular characterization and pharmacological properties of the human P2X3 purinoreceptor. Mol. Brain Res. 47 (1):59.

Spangler et al. (2011) Interaction of the diguanylate cyclase YdeH of Escherichia coli with 2', (3')-substituted purine and pyrimidine nucleotides. J. Pharmacol. Exp. Ther. 336 (1):234.